Brazil Syringe Market Size, Share, Opportunities, And Trends By Type (Insulin Syringe, Conventional Syringe), By Material (Glass, Plastic, Stainless Steel), By Syringe Size (Smaller Volume Syringe, Larger Volume Syringe) - Forecasts From 2023 To 2028

  • Published : Feb 2023
  • Report Code : KSI061614407
  • Pages : 120

The Brazilian syringe market is anticipated to develop due to the elevated frequency of chronic diseases, expanding need for vaccinations, advancements in technology, and an increase in the use of syringes for injecting pharmaceuticals. The country has seen a growth in surgeries and medical procedures recently, which is anticipated to drive the Brazil syringe market. In such treatments, these syringes are used to deliver liquids and remove bodily fluids. The most frequent surgical technique in Brazil where syringes are widely utilized is anesthesiology. It refers to the process of giving a patient medication to make the surgery more comfortable and painless. Hazardous living, inadequate athletic engagement, and nutrition, as well as substance and alcohol consumption, which has eventually led to an increase in the number of diseases as well as cancer cases in Brazil, are additional factors driving the market for syringes in that country. These factors have increased the demand for syringes for medical treatments.

The Brazil syringe market is driven by rising cancer and diabetes cases in the country.

As syringes are widely used for cancer treatments, the rising incidence of cancer has a substantial impact on the Brazilian syringes market, which is expected to expand significantly over the forecasted period. According to data from the Global Cancer Observatory, there were around 592,000 new cancer cases in 2020 and there were around 1.57 million prevalent cancer cases between 2015 and 2020. Additionally, the introduction of improved syringes, the rise in needle stick injuries, and technological developments in the healthcare sector are anticipated to drive market expansion.

Furthermore, as the elder population is more susceptible to certain chronic conditions like diabetes, the expanding aging population has an impact on the growth of the syringes market. According to reports from the International Diabetes Federation (IDF), there were around 15.73 million active diabetes patients in 2021 in Brazil. Along with population aging and rising life expectancy, growing urbanization and population lifestyle changes have also contributed to an increase in diabetes cases in the country. Additionally, type 2 diabetes is typically discovered late in the course of the illness, leaving many patients with chronic problems at the time of discovery. The bulk of direct treatment expenses are related to hospitals, and diabetes mortality has climbed dramatically in several regions of the country over the past years. As such, the demand for insulin syringes has increased in Brazil as a result of the widespread usage of these syringes in the treatment of diabetes, which has favorably impacted the Brazil syringe market.

Key Developments.

  • In January 2021, Syringes and needles were made available in Brazil duty-free as part of measures to fight the COVID-19 outbreak. The import fee for needles and syringes was eliminated by the Brazilian government. Previously, a 16% import charge applied to these goods, but due to the pandemic, the government temporarily eliminated that duty.
  • In June 2022, a major provider of syringes and medical technology, BD, reported receiving 2 billion injection devices worth of pandemic orders for needles and syringes to assist COVID-19 immunization campaigns worldwide. The accomplishment was the result of commitments made to governments around the world, including those of the United States, Brazil, France, Philippines, Saudi Arabia, South Africa, and the United Kingdom, among many others, as well as non-governmental organizations that support the distribution of vaccines in developing nations. In total, BD assisted more than 40 nations, non-governmental organizations, and other partners with pandemic orders. In order to assist the administration of vaccines, BD shipped more than 900 million injectable devices around the world in 2021.

The demand for hypodermic needles in the country has also benefitted the Brazil syringes market.

Healthcare practitioners typically utilize hypodermic needles. However, patients can administer drugs or medicines through hypodermic needles themselves. Patients with severe allergies or asthma, as well as diabetes, who need numerous doses of insulin daily, are the ones who use it the most frequently. As a result, the market for hypodermic needles is anticipated to grow as the occurrence of diabetes, asthma, and other severe allergies rises. Additionally, during the pandemic, the demand for blood samples significantly increased, which boosted the sales of hypodermic syringes and needles and has aided in the expansion of the Brazilian syringe market.

Key Market Segments

  • By Type
    • Insulin Syringe
    • Conventional Syringe
      • Eccentric Tip Syringe
      • Catheter Tip Syringe
      • Luer Lock Syringe
  • By Material
    • Glass
    • Plastic
    • Stainless Steel
  • By Syringe Size
    • Smaller Volume Syringe
    • Larger Volume Syringe


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Insulin Syringe

5.3. Conventional Syringe

5.3.1. Eccentric Tip Syringe

5.3.2. Catheter Tip Syringe

5.3.3. Luer Lock Syringe


6.1. Introduction

6.2. Glass

6.3. Plastic

6.4. Stainless Steel


7.1. Introduction

7.2. Smaller Volume Syringe

7.3. Larger Volume Syringe


8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisition, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix


9.1. BD

9.2. B. Braun Melsungen

9.3. Terumo

9.4. Teleflex

9.5. Nipro

9.6. ICU Medical, Inc.

9.7.  Hamilton Company


B. Braun Melsungen




ICU Medical, Inc.

 Hamilton Company